Benefitfocus (BNFT) Outlines 10-Year Vision
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Chardan Capital Markets Reiterates Buy on Benefitfocus (BNFT) Following Analyst Day
March 15, 2017 7:18 AM EDTChardan Capital Markets reiterated a Buy rating and $31.00 price target on Benefitfocus (NASDAQ: BNFT) following analyst day.
Analyst Steven Wardell commented, "We maintain our Buy rating on BNFT after attending their annual Analyst Day, at which product launches and a discussion of healthcare... More
